Acanthosis nigricans |
Classification and external resources |
Acanthosis nigricans on axilla
|
ICD-10 |
L83 |
ICD-9 |
701.2 |
OMIM |
100600 |
DiseasesDB |
58 |
MedlinePlus |
000852 |
eMedicine |
derm/1 |
MeSH |
D000052 |
Acanthosis nigricans is a brown to black, poorly defined, velvety hyperpigmentation of the skin. It is usually found in body folds,[1] such as the posterior and lateral folds of the neck, the axilla, groin, umbilicus, forehead, and other areas.
Contents
- 1 Causes
- 1.1 Endocrine
- 1.2 Malignant
- 1.3 Other
- 2 Types
- 2.1 Classification of Acanthosis nigricans according to Schwartz, 1994 [4][5]
- 2.2 Other Classifications of Acanthosis nigricans
- 3 Signs, tests, and misdiagnoses
- 4 Treatment
- 5 Prognosis
- 6 References
- 7 External links
Causes[edit]
It typically occurs in individuals younger than age 40, may be genetically inherited, and is associated with obesity or endocrinopathies, such as hypothyroidism, acromegaly, polycystic ovary disease, insulin-resistant diabetes, or Cushing's disease. Not associated with hyperthyroidism.
Endocrine[edit]
The most common cause of acanthosis nigricans is insulin resistance, which leads to increased circulating insulin levels. Insulin spillover into the skin results in its abnormal increase in growth (hyperplasia of the skin). The high insulin concentrations probably activate growth factor receptors (perhaps the IGF1 receptor) that drive the proliferation of keratinocytes and melanocytes. The condition most commonly associated with insulin resistance is type 2 diabetes mellitus, but is also a prominent feature of obesity, polycystic ovary syndrome and, Donohue syndrome.
Malignant[edit]
In the context of a malignant disease, acanthosis nigricans is a paraneoplastic syndrome and is then commonly referred to as acanthosis nigricans maligna. Involvement of mucous membranes is rare and suggests a coexisting malignant condition.[2]
When seen in individuals older than age 40, this disorder is commonly associated with an internal malignancy, usually adenocarcinoma, and most commonly of the GI tract or uterus; less commonly of the lung, prostate, breast, or ovary. The stomach is the most common site.[3] Acanthosis nigricans of the oral mucosa or tongue is highly suggestive of a neoplasm, especially of the GI tract.
Other[edit]
Other causes of acanthosis nigricans are familial, drug-induced and idiopathic.
Types[edit]
Classification of Acanthosis nigricans according to Schwartz, 1994 [4][5][edit]
- Benign acanthosis nigricans
- Acanthosis nigricans associated with obesity
- Syndromic acanthosis nigricans
- Malignant acanthosis nigricans
- Acral acanthosis nigricans
- Unilateral acanthosis nigricans
- Drug-induced acanthosis nigricans
- Mixed acanthosis nigricans
Other Classifications of Acanthosis nigricans[edit]
Acanthosis nigricans may also be divided into the following types[6]:506:
- Acral Acanthotic Anomaly (Acral Acanthosis Nigricans)
- Acanthosis nigricans type I
- Acanthosis nigricans type II
- Acanthosis nigricans type III
Signs, tests, and misdiagnoses[edit]
Physicians can usually diagnose acanthosis nigricans by simply looking at a patient's skin. A skin biopsy may be needed in unusual cases. If no clear cause of acanthosis nigricans is obvious, it may be necessary to search for one. Blood tests, an endoscopy, or x-rays may be required to eliminate the possibility of diabetes or cancer as the cause.
Additionally acanthosis nigricans has similar visual characteristics (neck discoloration) with Casal collar, which is a symptom of pellegra (a nutrient deficiency disease, easily remedied with supplementation). In early stages of discoloration, it is hard for a non trained eye to distinguish one from the other.
Treatment[edit]
People with acanthosis nigricans should be screened for diabetes and, although rare, cancer. Controlling blood glucose levels through exercise and diet often improves symptoms. Acanthosis nigricans maligna may resolve if the causative tumor is successfully removed.[7]
Prognosis[edit]
Acanthosis nigricans often fades if the underlying cause can be determined and treated appropriately.
References[edit]
- ^ "acanthosis nigricans" at Dorland's Medical Dictionary
- ^ Schnopp C, Baumstark J (2007). "Oral acanthosis nigricans". N Engl J Med 357 (9): e10. doi:10.1056/NEJMicm062917. PMID 17761587.
- ^ Rigel DS, Jacobs MI (1980). "Malignant acanthosis nigricans:a review". J Dermatol Surg Oncol 6 (11): 923. PMID 6257767.
- ^ Garofalo, L.; A.M. Biscozzi, V. Mastrandrea, E. Bonifazi (2003). "Acanthosis nigricans vulgaris. A marker of hyperinsulinemia.". Eur. J. Pediat. Dermatol. 13: 85–8. Retrieved 2010-07-29.
- ^ Schwartz, Robert A. (1994). "Acanthosis nigricans". Journal of the American Academy of dermatology 31 (1): 1–19. doi:10.1016/S0190-9622(94)70128-8. PMID 8021347.
- ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0-7216-2921-0.
- ^ Brown J, Winkelmann RK (1968). "Acanthosis nigricans: study of 90 cases". Medicine 47 (1): 33. PMID 4868603.
External links[edit]
- [1]
- AOCD
- http://www.skinsight.com/adult/acanthosisNigricans-references.htm
- 00001 at CHORUS
Pigmentation disorders/Dyschromia (L80–L81, 709.0)
|
|
Hypo-/
leucism |
Loss of melanocytes
|
vitiligo: Quadrichrome vitiligo · Vitiligo ponctué · syndromic (Alezzandrini syndrome · Vogt–Koyanagi–Harada syndrome)
melanocyte development: Piebaldism · Waardenburg syndrome · Tietz syndrome
|
|
Loss of melanin/
amelanism
|
albinism: Oculocutaneous albinism · Ocular albinism
melanosome transfer: Hermansky–Pudlak syndrome · Chédiak–Higashi syndrome · Griscelli syndrome (Elejalde syndrome · Griscelli syndrome type 2 · Griscelli syndrome type 3)
other: Cross syndrome · ABCD syndrome · Albinism–deafness syndrome · Idiopathic guttate hypomelanosis · Phylloid hypomelanosis · Progressive macular hypomelanosis
|
|
Leukoderma w/o
hypomelanosis
|
Vasospastic macule · Woronoff's ring · Nevus anemicus
|
|
Ungrouped
|
ungrouped: Nevus depigmentosus · Postinflammatory hypopigmentation · Pityriasis alba · Vagabond's leukomelanoderma · Yemenite deaf-blind hypopigmentation syndrome · Wende–Bauckus syndrome
|
|
|
Hyper- |
Melanin/
Melanosis/
Melanism
|
Reticulated
|
Dermatopathia pigmentosa reticularis · Pigmentatio reticularis faciei et colli · Reticulate acropigmentation of Kitamura · Reticular pigmented anomaly of the flexures · Naegeli–Franceschetti–Jadassohn syndrome · Dyskeratosis congenita · X-linked reticulate pigmentary disorder · Galli–Galli disease · Revesz syndrome
|
|
Diffuse/
circumscribed
|
Lentigo/Lentiginosis: Lentigo simplex · Liver spot · Centrofacial lentiginosis · Generalized lentiginosis · Inherited patterned lentiginosis in black persons · Ink spot lentigo · Lentigo maligna · Mucosal lentigines · Partial unilateral lentiginosis · PUVA lentigines
Melasma · Erythema dyschromicum perstans · Lichen planus pigmentosus · Café au lait spot · Poikiloderma (Poikiloderma of Civatte · Poikiloderma vasculare atrophicans) · Riehl melanosis
|
|
Linear
|
Incontinentia pigmenti · Scratch dermatitis · Shiitake mushroom dermatitis
|
|
Other/ungrouped
|
Acanthosis nigricans (Acral acanthotic anomaly) · Freckle · Familial progressive hyperpigmentation · Pallister–Killian syndrome · Periorbital hyperpigmentation · Photoleukomelanodermatitis of Kobori · Postinflammatory hyperpigmentation · Transient neonatal pustular melanosis
|
|
|
Other
pigments
|
iron: Hemochromatosis · Iron metallic discoloration · Pigmented purpuric dermatosis (Schamberg disease, Majocchi's disease, Gougerot–Blum syndrome, Doucas and Kapetanakis pigmented purpura/Eczematid-like purpura of Doucas and Kapetanakis, Lichen aureus, Angioma serpiginosum) · Hemosiderin hyperpigmentation
other metals: Argyria · Chrysiasis · Arsenic poisoning · Lead poisoning · Titanium metallic discoloration
other: Carotenosis · Tattoo · Tar melanosis
|
|
|
Dyschromatoses |
Dyschromatosis symmetrica hereditaria · Dyschromatosis universalis hereditaria
|
|
|
|
noco (i/b/d/q/u/r/p/m/k/v/f)/cong/tumr (n/e/d), sysi/epon
|
proc, drug (D2/3/4/5/8/11)
|
|
|
|
Cutaneous keratosis, ulcer, atrophy, and necrobiosis (L82–L94, 700–701.5)
|
|
Epidermal thickening |
- keratoderma: Keratoderma climactericum
- Paraneoplastic keratoderma
- Acrokeratosis paraneoplastica of Bazex
- Aquagenic keratoderma
- Drug-induced keratoderma
- Paraneoplastic keratoderma
- psoriasis
- Keratoderma blennorrhagicum
- keratosis: Seborrheic keratosis
- Clonal seborrheic keratosis
- Common seborrheic keratosis
- Irritated seborrheic keratosis
- Seborrheic keratosis with squamous atypia
- Reticulated seborrheic keratosis
- Dermatosis papulosa nigra
- Keratosis punctata of the palmar creases
- other hyperkeratosis: Acanthosis nigricans
- Confluent and reticulated papillomatosis
- Callus
- Ichthyosis acquisita
- Arsenical keratosis
- Chronic scar keratosis
- Hyperkeratosis lenticularis perstans
- Hydrocarbon keratosis
- Hyperkeratosis of the nipple and areola
- Inverted follicular keratosis
- Lichenoid keratosis
- Multiple minute digitate hyperkeratosis
- PUVA keratosis
- Reactional keratosis
- Stucco keratosis
- Thermal keratosis
- Viral keratosis
- Warty dyskeratoma
- Waxy keratosis of childhood
- other hypertrophy: Keloid
- Hypertrophic scar
- Cutis verticis gyrata
|
|
Necrobiosis/granuloma |
Necrobiotic/palisading |
- Granuloma annulare
- Perforating
- Generalized
- Subcutaneous
- Granuloma annulare in HIV disease
- Localized granuloma annulare
- Patch-type granuloma annulare
- Necrobiosis lipoidica
- Annular elastolytic giant cell granuloma
- Granuloma multiforme
- Necrobiotic xanthogranuloma
- Palisaded neutrophilic and granulomatous dermatitis
- Rheumatoid nodulosis
- Interstitial granulomatous dermatitis/Interstitial granulomatous drug reaction
|
|
Foreign body granuloma |
- Beryllium granuloma
- Mercury granuloma
- Silica granuloma
- Silicone granuloma
- Zirconium granuloma
- Soot tattoo
- Tattoo
- Carbon stain
|
|
Other/ungrouped |
|
|
|
Dermis/
localized CTD |
Cutaneous lupus
erythematosus |
- chronic: Discoid
- Panniculitis
- ungrouped: Chilblain
- Lupus erythematosus–lichen planus overlap syndrome
- Tumid
- Verrucous
- Rowell's syndrome
|
|
Scleroderma/
Morphea |
- Localized scleroderma
- Localized morphea
- Morphea–lichen sclerosus et atrophicus overlap
- Generalized morphea
- Atrophoderma of Pasini and Pierini
- Pansclerotic morphea
- Morphea profunda
- Linear scleroderma
|
|
Atrophic/
atrophoderma |
- Lichen sclerosus
- Anetoderma
- Schweninger–Buzzi anetoderma
- Jadassohn–Pellizzari anetoderma
- Atrophoderma of Pasini and Pierini
- Acrodermatitis chronica atrophicans
- Semicircular lipoatrophy
- Follicular atrophoderma
- Linear atrophoderma of Moulin
|
|
Perforating |
- Kyrle disease
- Reactive perforating collagenosis
- Elastosis perforans serpiginosa
- Perforating folliculitis
- Acquired perforating dermatosis
|
|
Skin ulcer |
|
|
Other |
- Calcinosis cutis
- Sclerodactyly
- Poikiloderma vasculare atrophicans
- Ainhum/Pseudo-ainhum
|
|
|
|
|
noco (i/b/d/q/u/r/p/m/k/v/f)/cong/tumr (n/e/d), sysi/epon
|
proc, drug (D2/3/4/5/8/11)
|
|
|
|
Paraneoplastic syndromes
|
|
Endocrine |
Hypercalcaemia · SIADH · Zollinger–Ellison syndrome · Cushing's syndrome
|
|
Hematological |
Granulocytosis · Multicentric reticulohistiocytosis
|
|
Neurological |
Paraneoplastic cerebellar degeneration · Encephalomyelitis · Limbic encephalitis · Opsoclonus · Polymyositis · Transverse myelitis · Lambert–Eaton myasthenic syndrome · Anti-NMDA receptor encephalitis
|
|
Musculoskeletal |
Dermatomyositis · Hypertrophic osteoarthropathy
|
|
Mucocutaneous |
reactive erythema: Erythema gyratum repens · Necrolytic migratory erythema
papulosquamous: Acanthosis nigricans · Acquired ichthyosis · Acrokeratosis paraneoplastica of Bazex · Extramammary Paget's disease · Florid cutaneous papillomatosis · Leser-Trélat sign · Pityriasis rotunda · Tripe palms
other/ungrouped: Febrile neutrophilic dermatosis · Pyoderma gangrenosum · Paraneoplastic pemphigus
|
|
|
|